The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas
- PMID: 21030073
- DOI: 10.1016/j.biomaterials.2010.09.065
The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas
Abstract
This study describes the creation and characterization of drug carriers prepared using the polymer poly[aniline-co-N-(1-one-butyric acid) aniline] (SPAnH) coated on Fe(3)O(4) cores to form three types of magnetic nanoparticles (MNPs); these particles were used to enhance the therapeutic capacity and improve the thermal stability of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a compound used to treat brain tumors. The average hydrodynamic diameter of the MNPs was 89.2 ± 8.5 nm and all the MNPs displayed superparamagnetic properties. A maximum effective dose of 379.34 μg BCNU could be immobilized on 1 mg of MNP-3 (bound-BCNU-3). Bound-BCNU-3 was more stable than free-BCNU when stored at 4 °C, 25 °C or 37 °C. Bound-BCNU-3 could be concentrated at targeted sites in vitro and in vivo using an externally applied magnet. When applied to brain tumors, magnetic targeting increased the concentration and retention of bound-BCNU-3. This drug delivery system promises to provide more effective tumor treatment using lower therapeutic doses and potentially reducing the side effects of chemotherapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.Oncol Rep. 2012 Jan;27(1):121-8. doi: 10.3892/or.2011.1459. Epub 2011 Sep 14. Oncol Rep. 2012. PMID: 21922149
-
Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer.Biomaterials. 2010 Oct;31(28):7355-63. doi: 10.1016/j.biomaterials.2010.05.061. Epub 2010 Jul 6. Biomaterials. 2010. PMID: 20609471
-
Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.J Neurol Surg A Cent Eur Neurosurg. 2012 May;73(3):132-41. doi: 10.1055/s-0032-1304216. Epub 2012 Apr 30. J Neurol Surg A Cent Eur Neurosurg. 2012. PMID: 22628080
-
The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.Neurosurg Clin N Am. 2012 Apr;23(2):289-95, ix. doi: 10.1016/j.nec.2012.01.004. Epub 2012 Feb 18. Neurosurg Clin N Am. 2012. PMID: 22440872 Review.
-
Risk management in the treatment of malignant gliomas with BCNU wafer implants.Cent Eur Neurosurg. 2010 Nov;71(4):199-206. doi: 10.1055/s-0029-1242775. Epub 2010 Jan 8. Cent Eur Neurosurg. 2010. PMID: 20063259 Review.
Cited by
-
Use of Super Paramagnetic Iron Oxide Nanoparticles as Drug Carriers in Brain and Ear: State of the Art and Challenges.Brain Sci. 2021 Mar 11;11(3):358. doi: 10.3390/brainsci11030358. Brain Sci. 2021. PMID: 33799690 Free PMC article. Review.
-
Optical assays based on colloidal inorganic nanoparticles.Analyst. 2018 Jul 21;143(14):3249-3283. doi: 10.1039/c8an00731d. Epub 2018 Jun 20. Analyst. 2018. PMID: 29924108 Free PMC article. Review.
-
Hyperthermia treatment advances for brain tumors.Int J Hyperthermia. 2020 Jul;37(2):3-19. doi: 10.1080/02656736.2020.1772512. Int J Hyperthermia. 2020. PMID: 32672123 Free PMC article. Review.
-
Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.Biomaterials. 2016 Sep;101:285-95. doi: 10.1016/j.biomaterials.2016.06.007. Epub 2016 Jun 4. Biomaterials. 2016. PMID: 27310916 Free PMC article.
-
Potential of magnetic nanoparticles for targeted drug delivery.Nanotechnol Sci Appl. 2012 Aug 27;5:73-86. doi: 10.2147/NSA.S35506. Nanotechnol Sci Appl. 2012. PMID: 24198498 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous